• Skip to primary navigation
  • Skip to main content
  • Skip to footer

RAIRDA HomepageRAIRDA

The Rare Autoimmune Rheumatic Disease Alliance

  • About us
    • Our members
    • About RAIRDs
    • Our board
    • Our story
  • What we do
    • Our priorities
    • A quality standard for rare disease
    • Publications
  • News
  • Get involved
    • Personal stories
    • Share your story
    • Campaign for us
  • Contact us
  • Search

Safe At Work: letter to employers, March 2022

We have published a safe at work letter for people with rheumatic diseases who are located in England and are at higher risk from Covid-19 to use in discussion with their employers about how to keep safe at work, updated as government guidance changes.

We want to highlight that the Government have confirmed that, because of their continuing increased risk from Covid, people who are immunosuppressed are still advised to:

“Work from home if this feels right for you – if you cannot work from home, speak to your employer about what arrangements they can make to reduce your risk”

We are concerned that this specific guidance for immunosuppressed people may have been lost in the overall guidance changes and we therefore urge employers to continue to do all they can to support requests to work from home from your employees at highest risk from Covid. To protect those who cannot work from home, reasonable adjustments and strict adherence to risk reducing measures (set out in working safely guidance) remains as important as ever.

In the letter, we have highlighted the following key points:

  • Ask people who test positive for Covid to follow Government guidance and stay at home
  • Enable working from home wherever possible for people at highest risk who request to do so
  • Reasonable adjustments

Download the Safe At Work letter and share it with your employer as you have discussions about your safety at work.

Share this post:

Share on Twitter Share on Facebook Share on LinkedIn Share on E-mail
More news
« Take action against ending free COVID-19 testing kits
RAIRDA launches fourth vaccination dose survey »

Footer

  • Twitter

RAIRDA is calling on you to raise the profile of rare autoimmune rheumatic diseases in Parliament. Send our template letter to your local representative today and help #ResetTheBalanceForRAIRDs. rairda.org/get-involved/2…

It's great to see that the 2023 Rare Diseases Action Plan references the recommendations made in RAIRDA's #ResettingTheBalance report, and that it highlights the work being done on a quality standard for rare disease by the IAG to the UK Rare Diseases Forum. twitter.com/DHSCgovuk/stat…

Our co-chair @lanyon_peter attended the #RareDiseaseDay parliamentary reception yesterday. It was a great opportunity to meet with others from the rare disease community, and to hear from @GeneticAll_UK, @LizTwistMP and @Helen_Whately. @MBythell pic.twitter.com/gPRAFGNL51

Take action this #RareDiseaseDay by contacting your parliamentary representative to ask them to advocate for people with RAIRDs. Together, we can #ResetTheBalanceForRAIRDs. rairda.org/get-involved/r…

This #RareDiseaseDay, read about RAIRDA's plan for #ResettingTheBalanceForRAIRDs, and how you can get involved rairda.org/rare-disease-d…

Contact us